Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
Abstract The expression of p16/CDKN2A, the second most commonly inactivated tumour suppressor gene in cancer, is lost in the majority of chordomas. However, the mechanism(s) leading to its inactivation and contribution to disease progression have only been partially addressed using small patient coh...
Main Authors: | Lucia Cottone, Nadia Eden, Inga Usher, Patrick Lombard, Hongtao Ye, Lorena Ligammari, Daniel Lindsay, Sebastian Brandner, Jože Pižem, Nischalan Pillay, Roberto Tirabosco, Fernanda Amary, Adrienne M Flanagan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | The Journal of Pathology: Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cjp2.156 |
Similar Items
-
Chordomas, malignant spinal tumors
by: Niki Adrian Calina, et al.
Published: (2016-03-01) -
Poorly differentiated chordoma
by: Li Yang, et al.
Published: (2022-06-01) -
Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining
by: Bharat Rekhi, et al.
Published: (2017-01-01) -
Perineal chordoma cutis, a rare localization for a rare pathology: a case report and consideration of the literature
by: Chennoufi Mehdi, et al.
Published: (2020-05-01) -
Chordoma: study of five cases
by: B Sigdel, et al.
Published: (2012-09-01)